Ketamine IV Therapy IV Therapy
Breakthrough treatment for depression and chronic pain
$400–$800
Per session
60 min
Session duration
7 Benefits
Documented effects
4
Active ingredients

Key Takeaways
- IV ketamine is a medical treatment, given under supervision, for treatment-resistant depression and certain chronic-pain conditions — not a wellness drip.
- Unlike standard antidepressants that take weeks, sub-anesthetic ketamine can ease depression and suicidal thoughts within hours to days by acting on glutamate/NMDA pathways.
- Sessions cost roughly $400–$800 and run about an hour, with monitoring during and after for blood pressure and dissociative effects.
- Evidence for short-term antidepressant effect is strong; questions remain about how long benefits last and the best long-term protocol.
What is Ketamine IV Therapy IV Therapy?
Ketamine IV therapy has emerged as one of the most significant breakthroughs in psychiatry and pain medicine in decades. Unlike traditional antidepressants that take weeks to work via serotonin pathways, sub-anesthetic IV ketamine produces rapid antidepressant effects — often within hours — by targeting NMDA glutamate receptors and promoting neuroplasticity. It is used clinically for treatment-resistant depression, major depressive disorder, suicidal ideation, PTSD, OCD, and chronic pain conditions including fibromyalgia, CRPS, and neuropathic pain. Administered in a clinical setting under medical supervision.
How Ketamine IV Therapy IV Therapy Works
Most antidepressants work slowly through serotonin pathways. Ketamine works differently: at low (sub-anesthetic) doses it blocks NMDA glutamate receptors and triggers a cascade that rapidly strengthens synaptic connections (neuroplasticity). This is why a single infusion can lift mood and reduce suicidal thinking within hours — a speed conventional medications cannot match.
It is delivered as a carefully dosed IV (commonly 0.5 mg/kg over about 40 minutes) in a monitored clinical setting. Patients experience a temporary dissociative, dreamlike state during the infusion. Because ketamine raises blood pressure and has misuse potential, it is screened for, dosed precisely, and supervised — it is never a casual add-on.
What's in a Ketamine IV Therapy Drip?
| Ingredient | What it does | Typical dose |
|---|---|---|
| Ketamine HCl (sub-anesthetic) | NMDA-receptor antagonist that rapidly promotes neuroplasticity and antidepressant effects. | ~0.5 mg/kg |
| Normal saline | Carrier fluid for controlled, slow infusion. | 50–100 mL |
| Midazolam (optional) | Occasionally used to ease anxiety during the session. | Provider-determined |
| Ondansetron (optional) | Prevents nausea, a possible side effect. | 4 mg |
What to Expect During a Ketamine IV Therapy Session
After psychiatric and medical screening, you are seated or reclined in a quiet room with blood-pressure and other monitoring. During the ~40–60 minute infusion most people feel floaty, dreamy, or dissociated; this is expected and fades soon after the drip ends. You cannot drive afterward and need someone to take you home.
Treatment is usually a series — often around six infusions over two to three weeks — followed by maintenance sessions if you respond. It is delivered alongside, not instead of, ongoing mental-health care, and works best as part of a treatment plan with a prescriber.
Benefits of Ketamine IV Therapy
Who is Ketamine IV Therapy Best For?
- Treatment-resistant depression
- Major depressive disorder
- PTSD and trauma
- Suicidal ideation (acute)
- OCD unresponsive to medication
- CRPS and neuropathic pain
- Fibromyalgia
- Chronic regional pain syndrome
Ketamine IV Therapy IV Therapy Cost
Starts from
$400
Typical high
$800
Session
60 min
What affects Ketamine IV Therapy pricing?
| Clinic vs. mobile (at-home) service | Mobile visits add a $25–$50 travel fee |
| Add-ons (glutathione, anti-nausea, extra B12) | +$25–$75 each |
| Dose / volume of the infusion | Higher doses sit at the top of the range |
| Membership or multi-session packages | Often 10–25% lower per session |
| Local market & cost of living | Major metros trend higher |
Evidence & Research
Ketamine has some of the strongest evidence of any therapy on this site. Berman and colleagues first reported rapid antidepressant effects in a controlled trial (Biological Psychiatry, 2000), and many randomized trials since have confirmed fast, significant short-term relief in treatment-resistant depression and acute suicidal ideation.
In 2017, a work group of the American Psychiatric Association published a consensus statement (Sanacora et al., JAMA Psychiatry) supporting ketamine’s use for mood disorders while emphasizing proper screening, monitoring, and clinician oversight. A related nasal-spray form (esketamine/Spravato) is FDA-approved for treatment-resistant depression.
The open questions are about durability and long-term safety: benefits can fade over days to weeks without maintenance, and optimal long-term protocols are still being defined. Bottom line — this is an evidence-backed psychiatric/pain treatment that belongs in a supervised clinical program, not a lifestyle infusion.
Ketamine IV Therapy vs. Other IV Drips
Ketamine IV Therapy vs. NAD+
NAD+ guideBoth are longer, higher-cost infusions, but they are unrelated: ketamine is a supervised psychiatric/pain treatment, while NAD+ is a wellness/longevity drip. Only ketamine has strong controlled evidence for its core use.
Ketamine IV Therapy vs. Magnesium
Magnesium guideFor chronic pain, magnesium is a low-cost, low-risk option, whereas ketamine is reserved for severe, refractory pain or depression and requires close monitoring.
Important Considerations
Always disclose the following conditions to your provider before receiving Ketamine IV Therapy therapy:
- Uncontrolled hypertension
- Active psychosis or schizophrenia
- Substance use disorder (ketamine)
- Unstable cardiovascular disease
- Pregnancy
- Poorly controlled thyroid disease
- History of mania without mood stabilizer
Ketamine IV Therapy IV Therapy — FAQs
Sources & References
- Berman RM, et al. Antidepressant effects of ketamine in depressed patients. (2000) — Biological Psychiatry
- Sanacora G, et al. A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. (2017) — JAMA Psychiatry
- Spravato (esketamine) — FDA prescribing information & approval — U.S. Food & Drug Administration
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. IV therapy should only be administered by licensed medical professionals. Always consult a qualified healthcare provider before starting any IV therapy treatment.